Total Payments
$1,483
2024 Payments
$428.25
Companies
13
Transactions
66
Medicare Patients
4,466
Medicare Billing
$315,117
Payment Breakdown by Category
Food & Beverage$1,483 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,483 | 66 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | $411.61 | 14 | $0 (2024) |
| Oyster Point Pharma, Inc. | $245.59 | 11 | $0 (2024) |
| ABBVIE INC. | $158.30 | 11 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $152.80 | 7 | $0 (2023) |
| Tarsus Pharmaceuticals, Inc. | $130.81 | 4 | $0 (2024) |
| Allergan, Inc. | $97.70 | 6 | $0 (2022) |
| CooperVision Inc. | $71.83 | 3 | $0 (2024) |
| Shire North American Group Inc | $63.07 | 3 | $0 (2018) |
| Carl Zeiss Meditec USA, Inc. | $44.33 | 2 | $0 (2024) |
| Dompe US, Inc. | $33.94 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $428.25 | 22 | ABBVIE INC. ($158.30) |
| 2023 | $542.51 | 19 | Sun Pharmaceutical Industries Inc. ($211.91) |
| 2022 | $196.58 | 9 | Sun Pharmaceutical Industries Inc. ($90.33) |
| 2021 | $117.58 | 6 | SUN PHARMACEUTICAL INDUSTRIES INC. ($45.89) |
| 2019 | $46.81 | 2 | Sun Pharmaceutical Industries Inc. ($46.81) |
| 2018 | $41.43 | 2 | Bausch & Lomb, a division of Bausch Health US, LLC ($21.43) |
| 2017 | $110.30 | 6 | Allergan Inc. ($52.15) |
All Payment Transactions
66 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Food and Beverage | In-kind items and services | $19.90 | General |
| Category: Ophthalmology | ||||||
| 12/09/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $19.44 | General |
| Category: EYE CARE | ||||||
| 11/18/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $35.06 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 11/12/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: EYE CARE | ||||||
| 10/22/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $12.75 | General |
| Category: EYE CARE | ||||||
| 09/19/2024 | Carl Zeiss Meditec USA, Inc. | — | Food and Beverage | In-kind items and services | $27.88 | General |
| 09/10/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $12.40 | General |
| Category: EYE CARE | ||||||
| 09/05/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $35.51 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 08/08/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $15.13 | General |
| Category: EYE CARE | ||||||
| 07/11/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: EYE CARE | ||||||
| 06/13/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: EYE CARE | ||||||
| 05/13/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $19.84 | General |
| Category: EYE CARE | ||||||
| 05/09/2024 | Alcon Vision LLC | Rocklatan (Drug) | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: Ophthalmology | ||||||
| 05/01/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $25.50 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 05/01/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: Ophthalmology | ||||||
| 04/30/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $10.13 | General |
| Category: EYE CARE | ||||||
| 04/02/2024 | Carl Zeiss Meditec USA, Inc. | — | Food and Beverage | In-kind items and services | $16.45 | General |
| 03/27/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $9.39 | General |
| Category: EYE CARE | ||||||
| 01/30/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $34.74 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 01/25/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $9.04 | General |
| Category: EYE CARE | ||||||
| 01/11/2024 | CooperVision Inc. | MyDay Contact Lens (Device) | Food and Beverage | In-kind items and services | $24.08 | General |
| Category: Devices | ||||||
| 01/02/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $18.83 | General |
| Category: Dry eyes | ||||||
| 12/13/2023 | Alcon Vision LLC | EYSUVIS (Drug) | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: Ophthalmology | ||||||
| 11/28/2023 | CooperVision Inc. | MyDay Contact Lens (Device) | Food and Beverage | In-kind items and services | $20.19 | General |
| Category: Devices | ||||||
| 11/22/2023 | CooperVision Inc. | MyDay Contact Lens (Device) | Food and Beverage | In-kind items and services | $27.56 | General |
| Category: Devices | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 1,250 | 1,460 | $388,409 | $86,015 |
| 2022 | 11 | 1,317 | 1,519 | $362,161 | $89,180 |
| 2021 | 10 | 1,080 | 1,263 | $289,178 | $84,922 |
| 2020 | 10 | 819 | 886 | $216,216 | $55,000 |
Total Patients
4,466
Total Services
5,128
Medicare Billing
$315,117
Procedure Codes
39
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92014 | Established patient complete exam of visual system | Office | 2023 | 474 | 533 | $195,078 | $46,133 | 23.6% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 213 | 268 | $67,804 | $16,214 | 23.9% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 78 | 78 | $33,696 | $7,487 | 22.2% |
| 92250 | Photography of the retina | Office | 2023 | 184 | 204 | $28,968 | $5,318 | 18.4% |
| 92133 | Imaging of optic nerve | Office | 2023 | 130 | 188 | $25,380 | $4,634 | 18.3% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 96 | 104 | $27,768 | $4,330 | 15.6% |
| 92134 | Imaging of retina | Office | 2023 | 53 | 63 | $8,505 | $1,766 | 20.8% |
| 76514 | Ultrasound scan of cornea to determine thickness | Office | 2023 | 22 | 22 | $1,210 | $131.85 | 10.9% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 268 | 277 | $101,382 | $25,755 | 25.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 253 | 332 | $73,010 | $21,025 | 28.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 130 | 140 | $40,530 | $9,565 | 23.6% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 78 | 78 | $31,085 | $8,197 | 26.4% |
| 92250 | Photography of the retina | Office | 2022 | 196 | 212 | $30,104 | $5,681 | 18.9% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 67 | 78 | $19,734 | $5,658 | 28.7% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 99 | 120 | $22,578 | $4,931 | 21.8% |
| 92133 | Imaging of optic nerve | Office | 2022 | 121 | 172 | $23,220 | $4,665 | 20.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 26 | 26 | $11,258 | $1,791 | 15.9% |
| 92134 | Imaging of retina | Office | 2022 | 53 | 58 | $7,830 | $1,721 | 22.0% |
| 76514 | Ultrasound scan of cornea to determine thickness | Office | 2022 | 26 | 26 | $1,430 | $189.38 | 13.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 353 | 395 | $112,180 | $36,344 | 32.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 184 | 272 | $57,120 | $18,564 | 32.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 115 | 115 | $49,795 | $13,407 | 26.9% |
| 92083 | Measurement of field of vision during daylight conditions, extended examination | Office | 2021 | 101 | 120 | $21,000 | $5,811 | 27.7% |
| 92133 | Diagnostic imaging of optic nerve of eye | Office | 2021 | 121 | 145 | $19,575 | $3,974 | 20.3% |
| 92134 | Diagnostic imaging of retina | Office | 2021 | 86 | 96 | $12,960 | $3,054 | 23.6% |
About Dr. Nirali Patel, O.D
Dr. Nirali Patel, O.D is a Optometrist healthcare provider based in Brookline, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/09/2010. The National Provider Identifier (NPI) number assigned to this provider is 1639401169.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nirali Patel, O.D has received a total of $1,483 in payments from pharmaceutical and medical device companies, with $428.25 received in 2024. These payments were reported across 66 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($1,483).
As a Medicare-enrolled provider, Patel has provided services to 4,466 Medicare beneficiaries, totaling 5,128 services with total Medicare billing of $315,117. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Ad
Practice Information
- Specialty Optometrist
- Other Specialties Optometrist
- Location Brookline, MA
- Active Since 02/09/2010
- Last Updated 07/21/2025
- Taxonomy Code 152W00000X
- Entity Type Individual
- NPI Number 1639401169
Products in Payments
- Cequa (Drug) $266.22
- TYRVAYA (Drug) $245.59
- XIIDRA (Drug) $200.79
- DURYSTA (Drug) $189.49
- XDEMVY (Drug) $130.81
- ILUMYA (Biological) $98.58
- MyDay Contact Lens (Device) $71.83
- RESTASIS (Drug) $52.15
- OXERVATE (Drug) $33.94
- XELPROS (Drug) $23.53
- CEQUA (Drug) $23.28
- LOTEMAX GEL (Drug) $21.43
- MIEBO (Drug) $19.90
- EYSUVIS (Drug) $16.82
- Rocklatan (Drug) $15.33
- ILEVRO (Drug) $15.08
- RESTASIS MULTIDOSE (Drug) $14.36
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Optometrist Doctors in Brookline
Anita Gulmiri, O.d, O.D
Optometrist — Payments: $31,900
Optometrist $31,900
Hui-Chu Chang, O.d., Ph.d, O.D., PH.D
Optometrist — Payments: $7,648
Optometrist $7,648
Dr. Linda Pham, O.d, O.D
Optometrist — Payments: $2,745
Optometrist $2,745
Dr. Debra Buduo, O.d, O.D
Optometrist — Payments: $2,705
Optometrist $2,705
Dr. Alexander Martin, Od, OD
Optometrist — Payments: $2,417
Optometrist $2,417
Stephanie Dunker, O.d, O.D
Optometrist — Payments: $1,906
Optometrist $1,906